CNBC's "Fast Money"

Treasury intervention sparks rate relief... And Moderna’s cancer moonshot 8/19/26

CNBC's "Fast Money"

Show Notes

Yields and the dollar moving sharply lower after the U.S. Treasury pledged to step up debt buybacks. The traders debate whether the move just gave stocks the all-clear. Then, Mizuho’s Jared Holz reacts to the huge moves higher in Moderna and Merck, after the pair’s personalized cancer vaccine succeeded in a pivotal trial. Plus, new signs OpenAI is falling behind Anthropic, Target delivers a bullseye for investors and a humanoid robot maker’s massive Shanghai debut.

Fast Money Disclaimer

More from CNBC's "Fast Money"

Oct 23, 2026

Even with tech putting in a losing week, investors begin to nibble on software and cyber stocks. The traders debate how to position in the AI trade amid the broader downdraft. Plus, energy stocks hit fresh records as oil rallies back. The Chart Master lays out the one group in the sector that could be poised to play catch-up. Plus, Williams-Sonoma’s dutch oven heats up, a potential delivery app deal and how options traders are positioned heading into next week’s key earnings reports.

Oct 22, 2026

Tech stocks plummeting in today’s selloff, as AI spending fears reach a boiling point. The AI names leading the carnage, and what Nvidia CEO Jensen Huang had to say about a lack of capital holding back growth. Plus, homebuilder stocks catch a bid as rates pull back, how carriers are slashing the iPhone Duo price to get your business, and Moderna’s meltdown; the leaked data that tanked shares, and how options traders are handling the drop in the stock.

Oct 21, 2026

Big Tech earnings kick off with Meta and Tesla both reporting results. The numbers from the quarters, and what top tech analyst Gene Munster is hearing on the company conference calls. Plus, IBM, Las Vegas Sands, and United Rentals delivers results, Wall Street takes a bite out of Chipotle shares, and Coreweave’s lingering debt concerns; why shares are still under pressure and the impact it’s having on the broader AI tech trade.

Oct 20, 2026

Netflix, SpaceX, and United Airlines all on the move after hours. The numbers from those earnings reports, and a top media analysts reaction to the streaming giant’s quarter. Plus, the prognosis on pharma and health care stocks, setting up ahead of Meta, Tesla, and IBM’s reports tomorrow, and the next move in neoclouds. What a top tech analyst makes of the recent debt distress, and his take on the latest deals in the space.

Oct 19, 2026

Could the pullback in the AI trade be a buying opportunity? Why analysts say the Coreweave unwind is overdone, and the headwinds facing the other neoclouds and tech stocks. Plus, banks under pressure post-earnings, a prime pick on Wall Street, and the next move in the energy sector; where a top oil analyst sees Crude and Bbrent heading next after the latest developments in the Middle East.

See all episodes →